Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating OsrHSA for efficacy and safety in patients with hepatic cirrhosis and hypoalbuminemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Cirrhosis
• Hypoalbuminemia

Drugs mentioned

• OsrHSA (null)

Snippet

Sponsor: Healthgen Biotechnology Corp. | Conditions: Hypoalbuminemia, Hepatic Cirrhosis | Phase 3 | Status: COMPLETED